Hua Xuande & family

CEO, Pharmaceuticals

CHINA

Real-Time Net Worth

$1.3B

Estimated based on Pharmaceuticals stock value as of March 6, 2026

+2.1% (24h)

Age

Source

Pharmaceuticals

Industry

Healthcare

Citizenship

CHINA

Biography

Hua Xuande, the chairman of Zhejiang ZoneBanner Jiuzhou Group, has built a significant fortune in the pharmaceuticals industry. As of April 1, 2024, his net worth is estimated at $1.4 billion. His wealth stems from his leadership of Zhejiang Jiuzhou Pharmaceutical, a Shanghai-listed company. Hua Xuande's career includes expanding production through acquisitions, such as the takeover of a Chinese subsidiary of Novartis. His daughter, Hua Lirong, also plays a key role, currently chairing Zhejiang Jiuzhou Pharmaceutical. The family's business ventures showcase strategic investments and expansion within the healthcare sector.

Fact Checked

Verified by Editorial Team

Live Data

Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Background

Information regarding Hua Xuande's early life is limited. However, it is known that he is the chairman of Zhejiang ZoneBanner Jiuzhou Group.

Rise to Success

Hua Xuande's success is primarily attributed to his leadership in the pharmaceutical industry, particularly through Zhejiang Jiuzhou Pharmaceutical. The company controls Shanghai-listed Zhejiang Jiuzhou Pharmaceutical. This strategic position has allowed him to accumulate substantial wealth.

Key Business Strategies

A key business strategy has been the expansion of Jiuzhou Pharmaceutical through strategic acquisitions. In September 2019, Jiuzhou Pharmaceutical acquired U.S. pharmaceutical ingredient firm PharmAgra Labs for $16 million. Furthermore, in 2019, the company took over a Chinese subsidiary of Swiss pharmaceutical maker Novartis to expand its production capabilities. His daughter, Hua Lirong, is also in a key leadership position as the chair of Zhejiang Jiuzhou Pharmaceutical. These moves demonstrate a focused approach to growth within the pharmaceutical sector.

Philanthropy

Specific philanthropic initiatives undertaken by Hua Xuande and his family are not widely reported in available sources.

Career Milestones

2019

Acquisition of PharmAgra Labs

Zhejiang Jiuzhou Pharmaceutical acquired U.S. pharmaceutical ingredient firm PharmAgra Labs.

2019

Takeover of Novartis Subsidiary

Jiuzhou took over a Chinese subsidiary of Swiss pharmaceutical maker Novartis to help expand its production.

Compare Hua Xuande & family

Net Worth Face-off

Hua Xuande & family vs Elon Musk

Compare Wealth →

Net Worth Face-off

Hua Xuande & family vs Jeff Bezos

Compare Wealth →

Net Worth Face-off

Hua Xuande & family vs Mark Zuckerberg

Compare Wealth →